The global syringes market size was valued at USD 10.15 billion in 2025. The market is projected to grow from USD 10.64 billion in 2026 to USD 15.09 billion by 2034, exhibiting a CAGR of 4.5% during the forecast period. Asia Pacific dominated the syringes market with a market share of 35.07% in 2025.
The increasing number of chronic conditions such as diabetes, cardiovascular diseases, and cancer is significantly boosting demand for injectable therapies. Hospitals, clinics, and diagnostic laboratories rely heavily on syringes for routine medical procedures, vaccination campaigns, and blood sampling. In addition, rising global vaccination programs and increasing awareness regarding infection control have increased the adoption of disposable and safety syringes. These factors collectively support the expansion of the Syringes Market worldwide.
Continue reading for more details:
https://www.fortunebusinessinsights.com/syringes-market-115104
Market Segmentation
The Syringes Market is segmented based on product type, volume capacity, material, usage, and end user. By product type, the market is divided into conventional syringes and safety syringes. Conventional syringes currently dominate the Syringes Market due to their cost-effectiveness, easy availability, and widespread use across healthcare facilities, particularly in developing countries. Safety syringes are gaining increasing adoption as healthcare systems focus on reducing needle-stick injuries and preventing infection transmission.
Based on volume capacity, the Syringes Market includes up to 1 mL, 1 mL–5 mL, 6 mL–10 mL, 11 mL–20 mL, and above 20 mL syringes. Among these, the 1 mL–5 mL segment holds the largest share of the global market due to its broad use in therapeutic injections, vaccinations, and outpatient medical procedures. These syringes provide accurate dosing and are commonly used for administering antibiotics, vaccines, insulin, and analgesics in hospitals and clinics.
By material type, the Syringes Market is categorized into plastic syringes and glass syringes. Plastic syringes dominate the market due to their affordability, disposability, and strong infection control benefits. Healthcare facilities prefer plastic syringes because they are lightweight, cost-efficient, and suitable for mass production, making them ideal for high-volume medical procedures.
Based on usage, the market is divided into disposable syringes and reusable syringes. Disposable syringes hold the largest share of the Syringes Market due to strict global infection prevention protocols that discourage reuse of medical devices. Healthcare authorities worldwide recommend single-use syringes to reduce the risk of disease transmission and ensure patient safety.
By end user, the Syringes Market includes hospitals and ambulatory surgical centers (ASCs), clinics, clinical laboratories, pharmaceutical and biotechnology companies, and others. Hospitals and ASCs account for the largest share of the market due to the high volume of injections, diagnostic procedures, and surgical treatments performed in these facilities.
Key Players
- Becton, Dickinson and Company
- Terumo Corporation
- Nipro Corporation
- Gerresheimer AG
- Cardinal Health
- B. Braun Melsungen AG
- Smiths Medical
- Hindustan Syringes & Medical Devices Ltd.
- Weigao Group
- Retractable Technologies, Inc.
Market Growth
The Syringes Market is growing steadily due to the increasing global burden of chronic diseases and the rising need for injectable drug administration. Conditions such as diabetes, cardiovascular diseases, and autoimmune disorders often require regular injections for treatment and disease management. As the number of patients suffering from these conditions continues to increase, the demand for syringes in hospitals, clinics, and home healthcare settings is also rising.
Vaccination programs worldwide are another major factor driving the Syringes Market. Governments and international health organizations conduct large-scale immunization campaigns to prevent infectious diseases. These vaccination programs require billions of syringes annually, which significantly increases the demand for disposable syringes. The growing focus on pandemic preparedness and immunization coverage further contributes to the expansion of the Syringes Market globally.
Technological advancements in drug delivery devices are also supporting market growth. Manufacturers are developing innovative syringe designs such as auto-disable syringes, safety syringes, and prefilled syringes to improve patient safety and reduce the risk of contamination. These innovations are increasingly adopted by healthcare providers, contributing to the growth of the Syringes Market. Additionally, pharmaceutical companies are increasingly using prefilled syringes for biologic drugs and vaccines, which simplifies administration and enhances dosing accuracy.
The expansion of healthcare infrastructure in emerging economies is another key factor boosting the Syringes Market. Countries in Asia Pacific, Latin America, and the Middle East are investing heavily in hospitals, diagnostic centers, and vaccination programs. As healthcare services expand in these regions, the demand for medical consumables such as syringes is increasing significantly.
Restraining Factors
Despite strong growth potential, several factors may restrain the expansion of the Syringes Market. One of the major challenges is the risk associated with improper disposal of medical waste. Used syringes can pose serious environmental and health hazards if not disposed of properly. Improper disposal can lead to accidental needle-stick injuries and the spread of infectious diseases, which remains a major concern in many developing countries.
Another restraining factor affecting the Syringes Market is the increasing adoption of alternative drug delivery technologies such as needle-free injection systems and transdermal drug delivery methods. These alternatives reduce the need for conventional injections in certain medical treatments and may limit long-term demand for traditional syringes.
In addition, stringent regulatory requirements related to medical device safety and quality standards can increase manufacturing costs for syringe manufacturers. Compliance with these regulations requires significant investment in product testing, manufacturing processes, and quality assurance systems, which may affect the profitability of companies operating in the Syringes Market.
Regional Analysis
From a regional perspective, the Syringes Market is segmented into Asia Pacific, North America, Europe, Latin America, and the Middle East & Africa. Among these regions, Asia Pacific dominates the global Syringes Market, accounting for a major share of global demand. The region’s market size reached USD 3.56 billion in 2025 and is estimated to reach USD 3.79 billion in 2026. The growth of the market in Asia Pacific is driven by the large population, expanding healthcare infrastructure, and increasing vaccination coverage in countries such as China, India, and Japan.
North America represents the second-largest region in the Syringes Market, with the market expected to reach approximately USD 2.51 billion in 2026. The region’s growth is supported by high healthcare spending, strong regulatory standards, and a large patient population requiring injectable therapies. In addition, the presence of leading medical device manufacturers and advanced healthcare systems further contributes to market expansion.
Europe also holds a significant share of the Syringes Market, supported by universal healthcare systems, increasing elderly populations, and strong government immunization programs. The region is witnessing increasing demand for injectable therapies used in chronic disease management and vaccination programs.
Meanwhile, Latin America and the Middle East & Africa are experiencing gradual growth in the Syringes Market due to improving healthcare infrastructure and rising awareness about infection prevention and vaccination programs. Governments in these regions are investing in public health systems and expanding access to essential medical supplies, including syringes, which is expected to support market growth in the coming years.